Andorra vs Early-demographic dividend: Immunization, measles second dose
Andorra
97.0%
in 2024
Early-demographic dividend
83.3%
in 2024
Andorra rank
19th
Early-demographic dividend rank
17th
Immunization, measles second dose over time
- Andorra
- Early-demographic dividend
How they compare
Andorra currently reports 97.0% against 83.3% in Early-demographic dividend, a difference of 13.7%.
That makes Andorra's figure about 1.2 times Early-demographic dividend's.
Across all 18 years both countries report, Andorra has been ahead every year.
Andorra ranks 19th and Early-demographic dividend ranks 17th of 178 countries.
Andorra has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Andorra | Early-demographic dividend | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 82.7% | 23.7% | 59.0% | Andorra |
| 2010s | 90.2% | 58.9% | 31.3% | Andorra |
| 2020s | 95.8% | 79.4% | 16.4% | Andorra |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles second dose, Andorra or Early-demographic dividend?
- Andorra, at 97.0% against 83.3% in Early-demographic dividend as of 2024.
- What is the difference in immunization, measles second dose between Andorra and Early-demographic dividend?
- 13.7%, with Andorra ahead.
- How many years of comparable data are there for Andorra and Early-demographic dividend?
- 18 years are reported by both, from 2007 to 2024.
- How do Andorra and Early-demographic dividend rank globally for immunization, measles second dose?
- Andorra ranks 19th and Early-demographic dividend ranks 17th of 178 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.